Artwork

Content provided by American Health Law Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Health Law Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Eli Lilly’s GLP-1 Litigation: Issues Related to Corporate Practice of Medicine and FDA Regulations

27:53
 
Share
 

Manage episode 487199382 series 2772159
Content provided by American Health Law Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Health Law Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In a groundbreaking development for the digital health world, Eli Lilly, one of the world’s largest pharmaceutical companies, has filed lawsuits against a growing number of telehealth companies over the sale of compounded drugs Mounjaro and Zepbound, two popular GLP-1 medications. Nawa Lodin, Associate, Wilson Sonsini Goodrich & Rosati, and Lauren Petrin, Associate, Wiley Rein, discuss the background of compounding and when it is allowed under FDA regulations; the legal and regulatory issues at play in Eli Lilly’s lawsuits, including issues related to the corporate practice of medicine and FDA regulations; and key compliance considerations.

Watch this episode: https://www.youtube.com/watch?v=XstaVQGtY24

Essential Legal Updates, Now in Audio

AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

Stay At the Forefront of Health Legal Education

Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

  continue reading

591 episodes

Artwork
iconShare
 
Manage episode 487199382 series 2772159
Content provided by American Health Law Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Health Law Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In a groundbreaking development for the digital health world, Eli Lilly, one of the world’s largest pharmaceutical companies, has filed lawsuits against a growing number of telehealth companies over the sale of compounded drugs Mounjaro and Zepbound, two popular GLP-1 medications. Nawa Lodin, Associate, Wilson Sonsini Goodrich & Rosati, and Lauren Petrin, Associate, Wiley Rein, discuss the background of compounding and when it is allowed under FDA regulations; the legal and regulatory issues at play in Eli Lilly’s lawsuits, including issues related to the corporate practice of medicine and FDA regulations; and key compliance considerations.

Watch this episode: https://www.youtube.com/watch?v=XstaVQGtY24

Essential Legal Updates, Now in Audio

AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

Stay At the Forefront of Health Legal Education

Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

  continue reading

591 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play